Kymera Therapeutics Inc (KYMR)

Operating Expenses

$140.61M

Quarterly · Period ending: · USD

KYMR logo

KYMR Operating Expenses

Latest reported$140.61M
KYMR Quarterly Operating Expenses ($12.81M → $140.61M)
High-resolution chart · PNG

KYMR operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
140,607,000
118,519,000
176,934,000
21,191,000
93,949,000
96,526,000
88,149,000
75,865,000
76,575,000
68,118,000
67,197,000
62,237,000
59,896,000
54,792,000
54,769,000
54,433,000
52,324,000
46,555,000
49,270,000
48,973,000
43,249,000
31,871,000
25,567,000
22,616,000
17,480,000
14,675,000
13,616,000
12,811,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.